Latest Blog Posts Tagged "Adenosine Receptors"
May 30, 2013
The announcement follows negative results from Merck on a similar therapeutic approach, leaving the field puzzled.
May 24, 2013
Discouraging news this week for the Parkinson's community, as drug giant Merck announced that they will discontinue their program developing a novel therapy for PD called preladenant.
March 04, 2013
A recent editorial asks if a cup of joe might help to prevent, or limit, the uncontrollable movements that are often a side effect of PD.
December 12, 2012
More positive trial results focused on adenosine were announced from another company - the British-based Vernalis - confirming the appropriate dose of V8144 to be used in a forthcoming trial.
December 11, 2012
Biotie Therapies is announcing positive clinical study results into a novel approach to treat symptoms of Parkinson's: In a phase 2b trial, tozadenant was found to significantly limit "off periods."